Health in Netherlands 310 indicators covering health for Netherlands. IndicatorLatest Year10-yr change Rank Population ages 80 and above, male 383,651 2025 up 42.9% 26th Prevalence of overweight, weight for height, female 5.0% 2024 up 25.0% 87th Prevalence of overweight, weight for height, male 5.8% 2024 up 26.1% 84th Prevalence of overweight, weight for height 5.4% 2024 up 25.6% 86th Prevalence of stunting, height for age, female 1.4% 2024 up 7.7% 158th Prevalence of stunting, height for age, male 1.8% 2024 up 5.9% 157th Prevalence of stunting, height for age 1.6% 2024 up 6.7% 157th Hospital beds 2.42 per 1,000 people 2022 down 35.3% 83rd Tuberculosis death rate 0.12 per 100,000 people 2024 down 42.9% 176th Incidence of tuberculosis 4.7 per 100,000 people 2024 down 14.5% 178th People using at least basic drinking water services, urban 100.0% 2024 unchanged 1st People using at least basic sanitation services, urban 97.5% 2024 unchanged 73rd People practicing open defecation, urban 0.0% 2024 — 95th People using at least basic drinking water services, rural 100.0% 2024 unchanged 1st People using at least basic sanitation services, rural 99.9% 2024 down 0.0% 13th People using at least basic drinking water services 100.0% 2024 unchanged 1st People using safely managed drinking water services 100.0% 2024 down 0.0% 12th People practicing open defecation, rural 0.0% 2024 — 103rd People using at least basic sanitation services 97.7% 2024 down 0.1% 78th Tuberculosis case detection rate 87.0% 2024 unchanged 51st People practicing open defecation 0.0% 2024 — 129th Current health expenditure 10.0% 2024 down 4.3% 29th Current health expenditure per capita 6,845 current US$ 2024 up 22.2% 11th Out-of-pocket expenditure 11.8% 2024 up 1.7% 159th Out-of-pocket expenditure per capita 806.89 current US$ 2024 up 24.3% 17th Domestic general government health expenditure 68.4% 2023 down 0.9% 59th Domestic general government health expenditure per capita, PPP 5,283 current international $ 2023 up 46.7% 15th Domestic private health expenditure 31.6% 2023 up 2.1% 110th Healthcare spending vs. GDP per capita 8,195 current international $ 2024 up 57.2% 10th Domestic private health expenditure per capita 2,015 current US$ 2023 up 17.6% 4th People using safely managed sanitation services 97.5% 2024 up 0.0% 15th Immunization, Hib3 89.0% 2024 down 7.3% 108th Child mortality vs. average years of schooling for women 0.3885 deaths per 100 live births 2024 down 5.6% 168th Reported cases of measles 202 Cases 2024 up 44.3% 75th Child mortality by income level of country 0.3885 deaths per 100 live births 2024 down 5.6% 168th Number of infant deaths 577 2024 down 6.3% 117th Number of under-five deaths 661 2024 down 8.6% 118th Number of neonatal deaths 450 2024 down 4.3% 114th Child mortality vs. health spending 0.3885 deaths per 100 live births 2024 down 5.6% 168th Share of one-year-olds vaccinated against measles 89.0% 2024 down 7.3% 105th Adolescent fertility rate 1.75 births per 1,000 women ages 15-19 2024 down 52.4% 203rd Sex ratio at birth 1.05 male births per female births 2024 up 0.5% 90th Domestic general government health expenditure 15.6% 2023 up 2.1% 38th External health expenditure 0.0% 2023 down 51.2% 142nd External health expenditure per capita 0.6678 current US$ 2023 down 43.8% 130th External health expenditure per capita, PPP 0.8098 current international $ 2023 down 27.7% 132nd Prevalence of anemia among women of reproductive age 16.5% 2023 up 31.0% 160th Prevalence of anemia among non-pregnant women 16.5% 2023 up 32.0% 160th Prevalence of anemia among pregnant women 16.5% 2023 down 4.6% 170th Stillbirth rate 2.2 per 1,000 total births 2023 down 8.3% 181st Children orphaned by HIV/AIDS 1,600 2023 up 14.3% 91st Life expectancy vs. health spending 82.16 years 2023 up 1.1% 34th Prevalence of undernourishment 2.5% 2023 unchanged 106th Immunization, measles second dose 81.0% 2024 down 12.9% 106th Antiretroviral therapy coverage 89.0% 2023 up 20.3% 21st Tuberculosis treatment success rate 79.0% 2023 down 10.2% 124th Prevalence of hypertension, female 24.8% 2019 down 20.3% 178th Prevalence of hypertension, male 36.2% 2019 down 11.1% 107th Prevalence of hypertension 30.5% 2019 down 15.0% 158th Treatment for hypertension, female 46.5% 2019 up 10.7% 105th ← Previous Page 4 of 6 Next →